Novartis Q4 Results slide image

Novartis Q4 Results

↓ ↑ Content Click below to navigate through the document Company overview Financial review Conclusions Appendix Innovation: Pipeline overview Financial performance Innovation: Clinical trials Cardiovascular, Renal and Metabolic > Immunology Neuroscience Oncology Other Global Health Abbreviations Immunology References □ NOVARTIS Reimagining Medicine Novartis Q4 Results | January 31, 2024 56
View entire presentation